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Reporting Checklist for Nature Neuroscience
This checklist is used to ensure good reporting standards and to improve the reproducibility of published results. For more information, please  
read Reporting Life Sciences Research. 
? ?
Please note that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the 
manuscript. 
 Statistics reporting, by figure
?  Please specify the following information for each panel reporting quantitative data, and where each item is reported (section, e.g. Results, & 
paragraph number). ?
??
??Each figure legend should ideally contain an exact sample size (n) for each experimental group/condition, where n is an exact number and not a  ?
   range, a clear definition of how n is defined (for example x cells from x slices from x animals from x litters, collected over x days), a description of  
   the statistical test used, the results of the tests, any descriptive statistics and clearly defined error bars if applicable. ? 
??
?  For any experiments using custom statistics, please indicate the test used and stats obtained for each experiment.??
??
?  Each figure legend should include a statement of how many times the experiment shown was replicated in the lab; the details of sample ?
   collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader.? 
??
?  For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number.?
 
Note: Mean and standard deviation are not appropriate on small samples, and plotting independent data points is usually more informative.  
When technical replicates are reported, error and significance measures reflect the experimental variability and not the variability of the biological 
process; it is misleading not to state this clearly.  
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 Representative figures
1.    Are any representative images shown (including Western blots and 
immunohistochemistry/staining) in the paper?  
If so, what figure(s)?
Fig 5a, supplementary Fig3 shows example neurons
2.    For each representative image, is there a clear statement of               
how many times this experiment was successfully repeated and a 
discussion of any limitations in repeatability?  
If so, where is this reported (section, paragraph #)?
Yes; All other figures show statistics across population of neurons
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 Statistics and general methods
1.    Is there a justification of the sample size? 
If so, how was it justified?  
Where (section, paragraph #)?  
       Even if no sample size calculation was performed, authors should 
report why the sample size is adequate to measure their effect size. 
No sample size calculation, but sample size of 651 neurons is well 
above the usual sample size for major human single neuron papers.
2.   Are statistical tests justified as appropriate for every figure?  
Where (section, paragraph #)?
Yes, extensively; Figure legends and methods specify throughout.
a.    If there is a section summarizing the statistical methods in 
the methods, is the statistical test for each experiment 
clearly defined? 
Yes
b.   Do the data meet the assumptions of the specific statistical 
test you chose (e.g. normality for a parametric test)?  
Where is this described (section, paragraph #)?
most comparison use permutation test (no distribution is assumed); 
if not, justification of assumption is stated.
c.    Is there any estimate of variance within each group of  data?  
Is the variance similar between groups that are being 
statistically compared?  
Where is this described (section, paragraph #)?
Variance is shown with errorbars
d.    Are tests specified as one- or two-sided? two-sided if not stated otherwise  
e.    Are there adjustments for multiple comparisons?  Yes, when needed (Cluster-size corrected)
3.    To promote transparency, Nature Neuroscience has stopped allowing 
bar graphs to report statistics in the papers it publishes. If you have 
bar graphs in your paper, please make sure to switch them to dot-
plots (with central and dispersion statistics displayed) or to box-and-
whisker plots to show data distributions.
Done
4.    Are criteria for excluding data points reported?  
Was this criterion established prior to data collection?  
Where is this described (section, paragraph #)? 
 
All well isolated neurons were included.
5.    Define the method of randomization used to assign subjects (or 
samples) to the experimental groups and to collect and process data.   
If no randomization was used, state so.  
Where does this appear (section, paragraph #)?
No randomization of subjects because all comparisons are within 
subject, trial-by-trial. 
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6.    Is a statement of the extent to which investigator knew the group 
allocation during the experiment and in assessing outcome included?   
If no blinding was done, state so.  
Where (section, paragraph #)?
No blinding was done, as stated.
7.    For experiments in live vertebrates, is a statement of compliance with 
ethical guidelines/regulations included?  
Where (section, paragraph #)?
Yes (methods)
8.    Is the species of the animals used reported?  
Where (section, paragraph #)?
Yes (Humans)
9.    Is the strain of the animals (including background strains of KO/
transgenic animals used) reported?  
Where (section, paragraph #)?
n/a
10.    Is the sex of the animals/subjects used reported?  
Where (section, paragraph #)?
Yes, Table S1
11.  Is the age of the animals/subjects reported?  
Where (section, paragraph #)?
Yes, Table S1
12.  For animals housed in a vivarium, is the light/dark cycle reported? 
Where (section, paragraph #)?
n/a
13.  For animals housed in a vivarium, is the housing group (i.e. number of 
animals per cage) reported? 
Where (section, paragraph #)?
n/a
14.  For behavioral experiments, is the time of day reported (e.g. light or 
dark cycle)?  
Where (section, paragraph #)?
n/a
15.  Is the previous history of the animals/subjects (e.g. prior drug 
administration, surgery, behavioral testing) reported? 
Where (section, paragraph #)? 
 
n/a
a.    If multiple behavioral tests were conducted in the same 
group of animals, is this reported? 
Where (section, paragraph #)?
16.  If any animals/subjects were excluded from analysis, is this reported?  
Where (section, paragraph #)?
None are excluded
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a.    How were the criteria for exclusion defined?  
Where is this described (section, paragraph #)?
b.    Specify reasons for any discrepancy between the number of 
animals at the beginning and end of the study.   
Where is this described (section, paragraph #)?
 Reagents
1.    Have antibodies been validated for use in the system under study 
(assay and species)? 
None used
a.    Is antibody catalog number given?  
Where does this appear (section, paragraph #)?
b.    Where were the validation data reported (citation, 
supplementary information, Antibodypedia)?  
Where does this appear (section, paragraph #)?
2.    Cell line identity 
                 a.     Are any cell lines used in this paper listed in the database of    
                         commonly misidentified cell lines maintained by ICLAC and  
                         NCBI Biosample?  
                  Where (section, paragraph #)?
None used
b.    If yes, include in the Methods section a scientific 
justification of their use--indicate here in which section and 
paragraph the justification can be found.
c.    For each cell line, include in the Methods section a 
statement that specifies: 
        - the source of the cell lines 
        - have the cell lines been authenticated? If so, by which   
          method? 
        - have the cell lines been tested for mycoplasma  
          contamination? 
Where (section, paragraph #)?
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 Data availability
Provide a Data availability statement in the Methods section under "Data 
availability", which should include, where applicable: 
• Accession codes for deposited data 
• Other unique identifiers (such as DOIs and hyperlinks for any other 
datasets) 
• At a minimum, a statement confirming that all relevant data are 
available from the authors 
• Formal citations of datasets that are assigned DOIs 
• A statement regarding data available in the manuscript as source 
data 
• A statement regarding data available with restrictions 
    
See our data availability and data citations policy page for more 
information. 
   
Data deposition in a public repository is mandatory for: 
     a. Protein, DNA and RNA sequences 
     b. Macromolecular structures 
     c. Crystallographic data for small molecules 
     d. Microarray data 
Deposition is strongly recommended for many other datasets for which 
structured public repositories exist; more details on our data policy 
are available here. We encourage the provision of other source data 
in supplementary information or in unstructured repositories such as 
Figshare and Dryad. 
We encourage publication of Data Descriptors (see Scientific Data) to 
maximize data reuse.  
 Where is the Data Availability statement provided (section, paragraph 
#)? 
We added a data availability statement to the manuscript.
 Computer code/software
Any custom algorithm/software that is central to the methods must be supplied by the authors in a usable and readable form for readers at the 
time of publication. However, referees may ask for this information at any time during the review process.
 1.   Identify all custom software or scripts that were required to conduct 
the study and where in the procedures each was used.
OSort for spike sorting and data analysis; EEGLAB for statistics, ndt 
for machine  learning; Custom Matlab code for analysis of 
attractors.
2.   If computer code was used to generate results that are central to the 
paper's conclusions, include a statement in the Methods section 
under "Code availability" to indicate whether and how the code can 
be accessed. Include version information as necessary and any 
restrictions on availability.
We added a code availability statement to the manuscript.
 Human subjects
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1.    Which IRB approved the protocol?  
Where is this stated (section, paragraph #)?
Cedars-Sinai Medical Center, Huntington Memorial Hospital and 
California Institute of Technology (3 IRB approvals); Methods.
2.    Is demographic information on all subjects provided?  
Where (section, paragraph #)?
Yes, Table S1
3.    Is the number of human subjects, their age and sex clearly defined?  
Where (section, paragraph #)?
Yes, Table S1
4.    Are the inclusion and exclusion criteria (if any) clearly specified?  
Where (section, paragraph #)? 
Sequential recruiting, all included who agreed
5.    How well were the groups matched?  
Where is this information described (section, paragraph #)?
n/a
6.    Is a statement included confirming that informed consent was 
obtained from all subjects? 
Where (section, paragraph #)?
Yes, Methods
7.    For publication of patient photos, is a statement included confirming 
that consent to publish was obtained? 
Where (section, paragraph #)?
No photos are included
 fMRI studies
For papers reporting functional imaging (fMRI) results please ensure that these minimal reporting guidelines are met and that all this 
information is clearly provided in the methods:
1.    Were any subjects scanned but then rejected for the analysis after the 
data was collected? 
Not an fMRI study
a.    If yes, is the number rejected and reasons for rejection 
described?  
Where (section, paragraph #)?
2.    Is the number of blocks, trials or experimental units per session and/
or subjects specified?  
Where (section, paragraph #)?
3.    Is the length of each trial and interval between trials specified? 
4.    Is a blocked, event-related, or mixed design being used? If applicable, 
please specify the block length or how the event-related or mixed 
design was optimized.
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5.    Is the task design clearly described?  
Where (section, paragraph #)?
6.    How was behavioral performance measured?
7.    Is an ANOVA or factorial design being used?
8.    For data acquisition, is a whole brain scan used?  
If not, state area of acquisition. 
a.    How was this region determined?
9.  Is the field strength (in Tesla) of the MRI system stated? 
a.    Is the pulse sequence type (gradient/spin echo, EPI/spiral) 
stated?
b.    Are the field-of-view, matrix size, slice thickness, and TE/TR/
flip angle clearly stated?
10.  Are the software and specific parameters (model/functions, 
smoothing kernel size if applicable, etc.) used for data processing and 
pre-processing clearly stated?
11.  Is the coordinate space for the anatomical/functional imaging data 
clearly defined as subject/native space or standardized stereotaxic 
space, e.g., original Talairach, MNI305, ICBM152, etc? Where (section, 
paragraph #)?
12.  If there was data normalization/standardization to a specific space 
template, are the type of transformation (linear vs. nonlinear) used 
and image types being transformed clearly described? Where (section, 
paragraph #)?
13.  How were anatomical locations determined, e.g., via an automated 
labeling algorithm (AAL), standardized coordinate database (Talairach 
daemon), probabilistic atlases, etc.?
14.  Were any additional regressors (behavioral covariates, motion etc) 
used?
15.  Is the contrast construction clearly defined? 
16.  Is a mixed/random effects or fixed inference used? 
a.    If fixed effects inference used, is this justified?
17.  Were repeated measures used (multiple measurements per subject)? 
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a.    If so, are the method to account for within subject 
correlation and the assumptions made about variance 
clearly stated?
18.  If the threshold used for inference and visualization in figures varies, is 
this clearly stated? 
19.  Are statistical inferences corrected for multiple comparisons? 
a.    If not, is this labeled as uncorrected?
20.  Are the results based on an ROI (region of interest) analysis? 
a.    If so, is the rationale clearly described? 
b.    How were the ROI’s defined (functional vs anatomical 
localization)? 
21.  Is there correction for multiple comparisons within each voxel? 
22.  For cluster-wise significance, is the cluster-defining threshold and the 
corrected significance level defined? 
 Additional comments
     Additional Comments
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